News

Podcast

Podcast: This Week in Managed Care—AZ Vaccine Linked With Rare Clotting Events and Other Health News

Author(s):

AJMC Staff

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a European safety committee finding very rare blood clot links with AstraZeneca’s COVID-19 vaccine; new report predicts shifts in the cancer landscape by 2040; the connected nature of type 1 diabetes with other autoimmune diseases.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Read more about the stories in this podcast:

What We're Reading: Global Coronavirus Coordinator Appointed; UK Variant in All 50 States; COVID-19 Impact on Athletes

What We’re Reading: Oxford Trial Paused; Brain Disorders in COVID-19 Patients; Multisystem Inflammatory Syndrome in Children

Cancer Landscape to Shift by 2040, New Report Says

Understanding the Connected Nature of Type 1 Diabetes, Other Autoimmune Diseases

Idiopathic Hypersomnia Campaign Seeks to Spread Awareness, Empower Patients

2021 Community Oncology Virtual Conference

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Pieter Sonneveld, MD, PhD
Carrie Kozlowski, OT, MBA, Upfront Healthcare
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Laurence Sperling, MD
Tiara Green MSEd
Tiara Green MSEd
Michael Morse, MD, Duke Cancer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Leslie Fish, PharmD.
Mila Felder, MD, FACEP
Related Content
Providers reported issues with accessing diagnostic tests, such as laboratory and lung function tests, and limited availability of pulmonary rehabilitation and home oxygen for rural patients. | Image credit: BJP7images - stock.adobe.com
June 7th 2025

Patients With ILD in Rural Areas Face Barriers to Care

AJMC Contributor
While citing overwhelming barriers patients in rural areas face when accessing care, providers noted the potential of telehealth to improve access in a survey.
managed care cast logo
June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS
Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
AJMC
June 4th 2025

Impact of COVID-19 on Specialty Televisits in a Large Integrated Health Care System

Joyce J. Kim, MD Robert G. Holleman, MPH Lewei (Allison) Lin, MD Sameer D. Saini, MD, MS Megan A. Adams, MD, JD, MSc
Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.
Managed Care Cast
June 3rd 2025

Managed Care Cast News Roundup: June 3, 2025

Giuliana Grossi
A quick roundup episode of major health policy developments, from shifting COVID-19 vaccine guidance and scientific publishing controversies to rising cancer care costs and the impact of oncology biosimilars.
Stethoscope and calculator on data and charts | Image Credit: © amazing studio - stock.adobe.com
June 3rd 2025

Contributor: Beyond the Sloganeering—A Data-Driven Analysis of Recent 340B Growth

William A. Sarraille, JD Shanyue Zeng, MA John Michael O’Brien, PharmD, MPH Rory Martin, PhD
This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price.
The new report highlights several barriers to CGT use, including cumbersome referral processes, high price tags, complex logistics, and uncertainties around reimbursement. | Image Credit: Treecha - stock.adobe.com
May 14th 2025

CGTs Have Potential to Transform Care, but Challenges Persist

Rose McNulty
Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from more widespread use, according to a new report from Cardinal Health.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo